StockData
XORTX Therapeutics Inc. logo

XORTX Therapeutics Inc. (XRTX) stock

XRTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 20, 2026Score 0/30
$1.06+0.02 (+1.92%)

Close on Nov 17, 2026Market cap $116.17KP/E –Yield –

XORTX Therapeutics EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

No eps figures for XORTX Therapeutics

XORTX Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More XORTX Therapeutics figures

See a number that looks wrong?